Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Micronized Purified Flavonoid Fraction (500mg) composed of Diosmin (450mg) + Hesperidin (50mg) Tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Blister
Packaging
5x2x10
Price
₹279/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Venoable 500 Tablet contains Micronized Purified Flavonoid Fraction (MPFF), a scientifically formulated blend of flavonoids with active components mainly consisting of diosmin and hesperidin. The micronization process improves absorption, bioavailability, and therapeutic efficacy compared to non-micronized forms. Favodio 500 is a well-recognized venoactive agent that enhances venous tone, reduces venous distension, protects microcirculation, and improves lymphatic drainage. It is widely used in the management of chronic venous insufficiency (CVI), varicose veins, and hemorrhoids. By strengthening vein walls and reducing capillary permeability, it alleviates symptoms such as pain, swelling, leg heaviness, and edema. In hemorrhoidal disease, it helps control inflammation, bleeding, and recurrence. The 500 mg strength is typically prescribed in divided doses for better therapeutic control, especially during acute hemorrhoidal attacks.
Venoable 500 Tablet is generally safe and well tolerated. Mild gastrointestinal discomfort such as nausea, abdominal pain, or diarrhea may occur in some patients. Occasional side effects include headache, dizziness, or skin rashes due to hypersensitivity. These effects are typically transient and resolve upon continuation or discontinuation of therapy.
Venoable 500 Tablet is indicated for the management of chronic venous insufficiency, including varicose veins, leg heaviness, pain, edema, and venous ulcers. It is also recommended for the treatment and prevention of acute and chronic hemorrhoidal episodes and as supportive therapy in lymphatic disorders linked to venous stasis.
Venoable 500 Tablet should be taken under medical supervision and as part of a comprehensive treatment plan including lifestyle modifications such as avoiding prolonged standing, elevating legs, and maintaining healthy body weight to improve venous return. It is not a replacement for surgical or procedural interventions in advanced venous disease but serves as an effective adjunctive therapy. Favodio 500 is generally considered safe during pregnancy (especially in the second and third trimesters) and lactation under physician guidance. In acute hemorrhoidal crises, adherence to the prescribed dosing schedule is essential for rapid symptom control. Patients with persistent or worsening symptoms should seek medical evaluation to rule out underlying conditions.
Store Venoable 500 Tablet in a cool, dry place below 30°C, away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children. Do not use beyond the expiry date printed on the pack.
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin (5mg) tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 40 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Micronized Purified Flavonoid Fraction (MPFF) 1000mg Tablet has strong demand in the vascular medicine, proctology, general surgery, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on venous health and chronic care portfolios.
Medical distributors and agencies can benefit from consistent demand for chronic venous disease and hemorrhoid management under medical supervision. Micronized Purified Flavonoid Fraction (MPFF) 1000mg (commonly containing Diosmin and Hesperidin) is a venoactive agent that helps improve venous tone, lymphatic drainage, and microcirculation Commonly prescribed for the management of chronic venous insufficiency (CVI), varicose veins, leg heaviness, leg pain, swelling (edema), nocturnal leg cramps, and acute or chronic hemorrhoidal disease, as advised by healthcare professionals Helps reduce venous inflammation, capillary permeability, and venous stasis, thereby improving symptoms associated with venous disorders and hemorrhoids The 1000mg tablet formulation supports convenient once-daily dosing in appropriate patients, enhancing treatment adherence and patient convenience Should be used under medical supervision and may be combined with lifestyle modifications, compression therapy, regular exercise, and weight management where appropriate. Persistent rectal bleeding or worsening venous symptoms should be medically evaluated Frequently utilized in vascular surgery clinics, proctology clinics, general surgery departments, hospitals, and general medicine practices Widely prescribed by vascular surgeons, proctologists, general surgeons, and general physicians for venous and hemorrhoidal disorders This strengthens a comprehensive vascular care and proctology portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Micronized Purified Flavonoid Fraction (MPFF) 1000mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent prescription demand, growing vascular and proctology market opportunities, long-term therapy requirements, reliable supply chain support, repeat business, and attractive margins in the venous healthcare segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality vascular and specialty healthcare products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.